India’s ambition to bring home API manufacture

India plans to establish mega parks for manufacturing active pharmaceutical ingredients. These shared facilities will have testing labs, effluent treatment sites, off grid power plants, intellectual property management etc. Financial assistance will be provided by the government to buy land and set up facilities.

The government also plans to launch equity funds to promote API manufacturing, the profits of which will be utilised for lifting duties on capital goods import, building infrastructure, promoting relationship between industry and academia, streamlining R & D and providing incentives to scientists.

We hope that these plans would create plenty of job opportunities and also help the budding scientists of India. If materialised, the plan may provide the much needed boost to the Indian Pharma industry.

Please read full article here.